z-logo
open-access-imgOpen Access
Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines
Author(s) -
Jinyu Xiang,
Wensheng Qiu,
Xingang Wang,
Fang Zhou,
Zhen Wang,
Shihai Liu,
Lu Yue
Publication year - 2013
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2013.2253
Subject(s) - downregulation and upregulation , erbb , gene silencing , oncogene , cancer research , breast cancer , blot , cancer , biology , cell cycle , medicine , gene , biochemistry
The ErbB-2 gene, whose overexpression is observed in many types of tumorsincluding breast cancer, plays an important role in carcinoma formation. Dysregulationof the human transforming acidic coiled-coil 1 (TACC1) and ErbB-2 genes is thoughtto be important in the development and progression of breast cancer. However,a putative interaction between ErbB-2 and TACC1 remains undetermined in breastcancer. After infecting BT474 cells with lentiviral-mediated ErbB2-specific shRNA,we detected the expression of ErbB-2 and TACC1 by real-time PCR and western blotting.ErbB-2 mRNA expression was decreased in the Lenti-ShERBB2 infected cells, andwestern blotting indicated a concordant reduction in ErbB-2 protein. TACC1 expressionat the mRNA and protein levels was significantly upregulated by ErbB-2 silencingin BT474 cells. CCK-8 assay indicated that the inhibition of ErbB-2 expressionincreased the sensitivity of BT474 cells to docetaxel treatment. These findingsprovide proof and the foundation for the molecular and biological relationshipsof ErbB-2 and TACC1 in breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom